C. N. Ferreira

Budget Impact Analysis Of Tofacitinib For Rheumatoid Arthritis From The Perspective Of The Brazilian Private Healthcare System.

M. Dulcine, C. N. Ferreira, C. Rufino, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost-Effectiveness of Apixaban Versus Other Noacs And Warfarin, During Hospitalization In The Private Brazilian Health System.

B. Donato, M. Preto, C. N. Ferreira, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Impact of parecoxib on hospital discharge: retrospective analysis of Brazilian health insurance

C. N. Ferreira, C. Santana, Lucas Fahham, 2016 .

Acromegaly Patients with Inadequate Response to Maximum Dose Octreotide-Lar Who Progress to Treatment with Pegvisomant: Economic Evaluation and Incremental Budget Impact Analysis from the Public Perspective to São Paulo State.

C. N. Ferreira, C. Rufino, C. Santana, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Using A HA-CMC Barrier To Avoid Pelvic Or Abdominal Adhesion: Cost-Benefit Advantages In A Private Health Care Setting

C. N. Ferreira, C. Santana, W. Follador, 2013 .

Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Private Health Care System in Brazil: Results from a 12-Month Retrospective Analysis of an Administrative Database

M. Pereira, E. Asano, C. N. Ferreira, 2013 .

The association between psoriasis and health-related quality of life, work productivity, and healthcare resource use in Brazil*

M. Dibonaventura, C. S. Souza, C. N. Ferreira, 2018, Anais brasileiros de dermatologia.